Improved diagnostic technologies are supporting the Cardiometabolic Disease Market by enabling more comprehensive assessment of patient risk. Biomarkers, laboratory testing, imaging, and digital monitoring tools are contributing to more informed clinical decision-making. The cardiometabolic disease market is expected to reach US$ 155.56 billion by 2034 from US$ 109.28 billion in 2025,...